Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
TherapeuticsMD Stock Quote

TherapeuticsMD (NASDAQ: TXMD)

$1.89
(-0.5%)
-$0.01
Price as of April 17, 2024, 3:59 p.m. ET

TherapeuticsMD Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TXMD -48.23% -99.10% -61.03% -96%
S&P +20.88% +72.88% +11.56% +301%

TherapeuticsMD Company Info

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.